Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease

被引:3
|
作者
De, Tanima [1 ]
Zhang, Honghong [1 ]
Alarcon, Cristina [1 ]
Lec, Bianca [1 ]
Avitia, Juan [1 ]
Smithberger, Erin [2 ]
Chen, Chuyu [1 ]
Horvath, Minnie [1 ]
Kwan, Sara [3 ]
Young, Mary [3 ]
Adhikari, Sarbani [3 ]
Kwon, John [2 ]
Pacheco, Jennifer [1 ]
Jarvik, Gail [4 ,5 ]
Wei, Wei-Qi [6 ]
Mentch, Frank [7 ]
Hakonarson, Hakon [7 ,8 ]
Sleiman, Patrick [7 ,8 ]
Gordon, Adam [1 ]
Harley, John [9 ,10 ]
Linneman, Jim [11 ]
Hebbring, Scott [12 ]
Parisiadou, Loukia [1 ]
Perera, Minoli A. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA
[6] Vanderbilt Univ, Med Ctr, Biomed Informat, Nashville, TN USA
[7] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
[8] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA
[10] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[11] Marshfield Clin Res Inst, Off Res Comp & Analyt, Marshfield, WI USA
[12] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA
来源
PHARMACOGENETICS AND GENOMICS | 2022年 / 32卷 / 01期
关键词
anti-TNF alpha; genome-wide association study; inflammatory bowel disease; primary nonresponse; single-nucleotide polymorphism; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; MANIFESTATIONS; POLYMORPHISMS; VARIANTS; DRUG; METAANALYSIS; IMPUTATION;
D O I
10.1097/FPC.0000000000000445
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Primary nonresponse (PNR) to antitumor necrosis factor-alpha (TNF alpha) biologics is a serious concern in patients with inflammatory bowel disease (IBD). We aimed to identify the genetic variants associated with PNR. Patients and methods Patients were recruited from outpatient GI clinics and PNR was determined using both clinical and endoscopic findings. A case-control genome-wide association study was performed in 589 IBD patients and associations were replicated in an independent cohort of 293 patients. Effect of the associated variant on gene expression and TNF alpha secretion was assessed by cell-based assays. Pleiotropic effects were investigated by Phenome-wide association study (PheWAS). Results We identified rs34767465 as associated with PNR to anti-TNF alpha therapy (odds ratio: 2.07, 95% CI, 1.46-2.94, P = 2.43 x 10(-7), [replication odds ratio: 1.8, 95% CI, 1.04-3.16, P = 0.03]). rs34767465 is a multiple-tissue expression quantitative trait loci for FAM114A2. Using RNA-sequencing and protein quantification from HapMap lymphoblastoid cell lines (LCLs), we found a significant decrease in FAM114A2 mRNA and protein expression in both heterozygous and homozygous genotypes when compared to wild type LCLs. TNF alpha secretion was significantly higher in THP-1 cells [differentiated into macrophages] with FAM114A2 knockdown versus controls. Immunoblotting experiments showed that depletion of FAM114A2 impaired autophagy-related pathway genes suggesting autophagy-mediated TNF alpha secretion as a potential mechanism. PheWAS showed rs34767465 was associated with comorbid conditions found in IBD patients (derangement of joints [P = 3.7 x 10(-4)], pigmentary iris degeneration [P = 5.9 x 10(-4)], diverticulum of esophagus [P = 7 x 10(-4)]). Conclusions We identified a variant rs34767465 associated with PNR to anti-TNF alpha biologics, which increases TNF alpha secretion through mechanism related to autophagy. rs34767465 may also explain the comorbidities associated with IBD.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] ACTIVE TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER TREATMENT WITH ANTI-TNF THERAPY
    Owen, L.
    Thi, A. A.
    Bouri, S.
    Wolfson, P.
    Abbara, A.
    John, L.
    Davidson, R. N.
    Hart, A. L.
    GUT, 2016, 65 : A252 - A253
  • [42] ADVERSE EVENTS IN ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS MANAGED WITH ANTI-TNF THERAPY
    Winters, Conchubhair
    Mooney, Peter
    GUT, 2018, 67 : A101 - A101
  • [43] Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
    Estevez-Gil, M.
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Martinez-Cadilla, J.
    Pereira, S.
    Rodriguez-Prada, J-I
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
  • [44] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Bessissow, Talat
    Vutcovici, Maria
    Lakatos, Peter L.
    Brassard, Paul
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 176 - 182
  • [45] Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
    de Jong, M. E.
    Smits, L. J. T.
    van Ruijven, B.
    den Broeder, N.
    Russel, M. G. V. M.
    Romkens, T. E. H.
    West, R. L.
    Jansen, J. M.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 888 - 895
  • [46] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Orfanoudaki, E.
    Foteinogiannopoulou, K.
    Andreou, N. P.
    Gazouli, M.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I354 - I355
  • [47] Guide to Discussing the Risks of Immunomodulator and Anti-TNF Therapy with Inflammatory Bowel Disease Patients
    Siegel, Corey A.
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (11) : 14 - +
  • [48] Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
    Herrinton, Lisa J.
    Liu, Liyan
    Weng, Xiaoping
    Lewis, James D.
    Hutfless, Susan
    Allison, James E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12): : 2146 - 2153
  • [49] Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy
    Iriarte, Ainara
    Zaera, Celia
    Bachiller-Corral, Javier
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (02): : 117 - 121
  • [50] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708